Case report: The MSI-L/p-MMR metastatic rectal cancer patient who failed systemic therapy responds to anti-PD-1 immunotherapy after stereotactic body radiation-therapy.

Liu, Shijin; Zhang, Yiran; Lin, Yujian; Wang, Peize; Pan, Yunlong

Liu, Shijin; Zhang, Yiran; Lin, Yujian; Wang, Peize; Pan, Yunlong.

Afiliação

Liu S; Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Zhang Y; Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Lin Y; Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Wang P; Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Pan Y; Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.

Front Immunol ; 13: 981527, 2022.

Article em En | MEDLINE | ID: mdl-36119063

Assuntos

Neoplasias Colorretais; Neoplasias Hepáticas; Radiocirurgia; Neoplasias Retais; Antígeno B7-H1; Biomarcadores Tumorais; Carboidratos; Antígeno Carcinoembrionário; Neoplasias Colorretais/tratamento farmacológico; Neoplasias Colorretais/terapia; Reparo de Erro de Pareamento de DNA; Humanos; Imunoterapia/métodos; Neoplasias Hepáticas/genética; Neoplasias Hepáticas/terapia; Instabilidade de Microssatélites; Neoplasias Retais/genética; Neoplasias Retais/terapia

Palavras-chave

MSS/MSI-L/p-MMR; SBRT; advanced rectal cancer; immunotherapy; liver metastasis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Neoplasias Colorretais / Radiocirurgia / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google